Ellison Mark Jason Heath
- SEC CIK
- 0001781982
No open-market purchases or sales filed in the past year.
Current role at each company
- OPNT Opiant Pharmaceuticals, Inc.Chief Development Officeras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ellison Mark Jason Heath as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 (view filing) | Jan 27 | 4 days | Ellison Mark Jason HeathChief Development Officer | SSale | −610 | $20.26 | −$12.4K | −3.2%18.8K after | |
| Jan 9, 2023 (view filing) | Jan 9 | Same day | Ellison Mark Jason HeathChief Development Officer | SSale | −469 | $20.20 | −$9.47K | −2.4%19.4K after | |
| Jan 5, 2023 (view filing) | Jan 5 | Same day | Ellison Mark Jason HeathChief Development Officer | SSale | −1.81K | $20.20 | −$36.5K | −8.3%19.8K after |